MAXCYTE, INC.·4

Apr 17, 4:14 PM ET

Ahuja Parmeet 4

Research Summary

AI-generated summary

Updated

MaxCyte (MXCT) CFO Parmeet Ahuja Receives 187,500 RSUs

What Happened

  • Parmeet Ahuja, Chief Financial Officer of MaxCyte, was granted 187,500 restricted stock units (RSUs) on April 15, 2026. The RSUs were awarded at $0.00 per share (i.e., no purchase price); the grant itself has no immediate cash cost to the reporting person.

Key Details

  • Transaction date: 2026-04-15; Form 4 filed 2026-04-17 (timely within the usual two-business-day window).
  • Security and amount: 187,500 RSUs (transaction code A = award/grant).
  • Price: $0.00 per share for the RSUs; total immediate value reported as $0 (value realizes only if/when RSUs vest and convert to shares).
  • Shares owned after transaction: not disclosed in the filing.
  • Footnote: These RSUs vest 25% on March 30, 2027, with the remaining 75% vesting in three equal annual installments thereafter, contingent on continued service.

Context

  • RSUs are a form of equity compensation that convert to shares upon vesting; they are not an open-market purchase or sale and do not indicate an immediate buying or selling signal.
  • This grant is a compensation award subject to time-based vesting and potential tax withholding at vesting; it should be viewed as part of executive pay rather than an active market trade.